American Gene Technologies (AGT), a leading gene and cell therapy company based in Rockville, MD, selected the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) as a new clinical site for its non-IND study, AGT-CS168, to collect clinical specimens from HIV positive individuals. AGT will use these materials to validate the patient-specific AGT103-T therapeutic manufacturing process. AGT expects AGT103-T will eliminate HIV from the body when infused back into the patient and will decrease or eliminate the need for lifelong antiretroviral treatment.
{iframe}https://www.americangene.com/press-releases/hiv-cure-program-of-american-gene-technologies-adds-university-of-maryland-school-of-medicines-institute-of-human-virology-as-new-study-site-to-support-the-development-of-a-cell-and-gene-ther/{/iframe}